Aprio Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.61M Buy
35,856
+125
+0.3% +$14.6K 0.23% 90
2026
Q1
$4.3M Buy
35,731
+996
+3% +$115K 0.23% 81
2025
Q4
$3.66M Buy
34,735
+26,931
+345% +$2.53M 0.21% 86
2025
Q3
$655K Buy
7,804
+776
+11% +$63.9K 0.07% 178
2025
Q2
$556K Buy
7,028
+288
+4% +$22.9K 0.06% 173
2025
Q1
$605K Sell
6,740
-77
-1% -$7.19K 0.08% 154
2024
Q4
$678K Sell
6,817
-287
-4% -$29.6K 0.1% 112
2024
Q3
$807K Sell
7,104
-181
-2% -$21.5K 0.13% 93
2024
Q2
$902K Buy
7,285
+455
+7% +$58.6K 0.16% 75
2024
Q1
$901K Buy
6,830
+2,767
+68% +$341K 0.18% 70
2023
Q4
$443K Buy
4,063
+327
+9% +$33.9K 0.1% 100
2023
Q3
$385K Buy
3,736
+1,376
+58% +$148K 0.11% 96
2023
Q2
$272K Sell
2,360
-377
-14% -$42.8K 0.07% 115
2023
Q1
$291K Buy
+2,737
New +$296K 0.09% 100
2020
Q4
Sell
-3,225
Closed -$255K 59
2020
Q3
$255K Hold
3,225
0.18% 57
2020
Q2
$238K Hold
3,225
0.23% 56
2020
Q1
$237K Hold
3,225
0.3% 49
2019
Q4
$280K Buy
+3,225
New +$265K 0.21% 53

Other funds holding MRK

Aprio Wealth Management's MRK Position: Q2 2026 in Review

Aprio Wealth Management increased its Merck (MRK) stake by 0.35% in Q2 2026, buying an estimated $14.6K and bringing the position to 35,856 shares worth $4.61M. The position accounts for 0.23% of the portfolio, ranked #90.

Aprio Wealth Management first reported a position in MRK in Q4 2019 and has held it in 18 quarters since. 1,803 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Aprio Wealth Management held 35,856 shares of Merck worth $4.61M as of Q2 2026.
  • Aprio Wealth Management bought 125 Merck shares in Q2 2026, an estimated $14.6K.
  • Merck made up 0.23% of Aprio Wealth Management's portfolio in Q2 2026, its #90 holding.
  • Aprio Wealth Management first reported a position in Merck in Q4 2019 and has held it in 18 quarters since.
  • 1,803 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Aprio Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.